BioPharmSignal logoBioPharmSignal

Biotech News

Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026

Wave Life Sciences (WVE)Wave Life SciencesEarnings

Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, October 27, 2026, to review the company’s third quarter 2026 financial results and provide business updates.

Related news

WVEWave Life Sciences2026-07-23 12:30 EST

Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026

WVEWave Life Sciences2026-04-22 12:30 EST

Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026

SLSSELLAS Life Sciences Group, Inc.2025-11-12 21:05 EST

SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

KZRKezar Life Sciences2019-11-06 21:05 EST

Kezar Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update

SLSSELLAS Life Sciences Group, Inc.2026-08-11 20:05 EST

SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

ACHVAchieve Life Sciences2026-08-11 12:30 EST

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates

ACHVAchieve Life Sciences2026-05-12 11:00 EST

Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates

KZRKezar Life Sciences2020-05-07 20:01 EST

Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update

RGENRepligen2026-10-27 11:00 EST

Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

TECHBio-Techne2026-04-14 11:00 EST

Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results

View all latest news

Wave Life Sciences

RNA Medicines Platform Company Wave Life Sciences is a clinical-stage biotechnology company developing RNA medicines across both rare and common diseases. Its PRISM platform combines RNA-targeting modalities, chemistry innovation, and human genetics to design medicines that can address disease biology through RNAi and RNA...

Recent company news

WVEWave Life Sciences2026-10-20 12:30 EST

Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026

WVEWave Life Sciences2026-10-19 12:30 EST

Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026

WVEWave Life Sciences2026-10-13 12:30 EST

Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference

WVEWave Life Sciences2026-10-01 11:30 EST

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

WVEWave Life Sciences2026-09-30 11:30 EST

Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development

Stock data

Close
3.22 USD
Market cap
1.09B USD
Exchange
NASDAQ
Sector
Life Science Tools
Location
United States